Monsanto to sales and distribution facilities in 51 countries. In 2005, it finalized the purchase of Seminis Inc, a leading global vegetable and fruit seed company, for $1.4 billion. This made it the world's largest conventional seed company. In 1999 Monsanto sold off NutraSweet Co. In December of the same year, Monsanto agreed to merge with Pharmacia & Upjohn, in a deal valuing the transaction at $27 billion. The agricultural division became a wholly owned subsidiary of the "new" Pharmacia; Monsanto's medical research division, which included products such as Celebrex. In 2000: Pharmacia spun off its agro-biotech subsidiary into a new
March Against Monsanto between industry and government". They also believe that there has been a conflict of interest between former employees of Monsanto who work for the U.S. Food and Drug Administration, and that Monsanto has used their patent rights to create a monopoly of the food supply which has resulted in economic losses by small farmers. Activist and journalist Emilie Rensink, who helped organize the march, said that in her view the appointment of ex-Monsanto executives to head the FDA has resulted in political favoritism, including Monsanto subsidies which have given them an unfair advantage over small farmers. Organizer Canal points to